Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 27 Nov 2002, 13:19 Sekunjalo Investments Limited - Final Audited Resu
August 2002                                                                     
Sekunjalo Investments Limited                                                   
(Incorporated in the Republic of South Africa)                                  
Registration number 1996/006093/06                                              
Share Code: SKJ                                                                 
ISIN: ZAE000017893                                                              
("Sekunjalo")                                                                   
HIGHLIGHTS                                                                      
- Group Headline Earnings     R16 918m                                          
- Group Turnover              R346 013m                                         
- Operating Profit            R49 207m                                          
- Headline EPS                19 cents                                          
BALANCE SHEET AT 31 AUGUST 2002                                                 
                                                      GROUP                     
2002          2001             
                                                 R`000         R`000            
ASSETS                                                                          
Non-current assets                               140 925       131 858          
Investment property                              350           -                
Property, plant and equipment                    61 887        61 779           
Deferred expenditure                             2 509         3 040            
Goodwill                                         7 859         5 932            
Intangible assets                                11 192        12 393           
Pharmaceutical dossiers                          30 600        32 300           
Investments                                      12 741        9 720            
Deferred taxation                                7 494         1 098            
Loans receivable                                 6 293         5 596            
Current assets                                   162 516       114 630          
Inventory                                        43 174        36 334           
Contract work in progress                        -             7 227            
Trade and other receivables                      62 921        57 007           
Cash and cash equivalents                        56 421        14 062           
TOTAL ASSETS                                     303 441       246 488          
EQUITY AND LIABILITIES                                                          
Capital and reserves                             21 700        4 779            
Share capital                                    1 554         1 554            
Share premium                                    126 283       126 283          
Non-distributable reserves                       39            39               
Accumulated loss                                 (106 176)    (123 097)         
Outside shareholders` interest                   46 251        52 140           
Non-current liabilities                          88 879        84 089           
Interest-bearing borrowings                      88 430        83 455           
Non-interest-bearing borrowings                  449           634              
Current liabilities                              146 611       105 480          
Trade and other payables                         62 492        53 418           
Shareholders for dividends                       684           -                
Current portion of long-term borrowings          28 805        25 802           
Bank overdraft                                   40 592        20 066           
Taxation                                         14 038        6 194            
TOTAL EQUITY AND LIABILITIES                     303 441       246 488          
TOTAL ASSETS                                     303 441       246 488          
- Continued operations                           302 615       244 068          
- Discontinued operations                        826           2 420            
TOTAL LIABILITIES                                235 490       189 569          
- Continued operations                           232 958       187 016          
- Discontinued operations                        2 532         2 553            
INCOME STATEMENT FOR THE YEAR ENDED                                             
31 AUGUST 2002                                                                  
GROUP                    
                                                 2002          2001             
                                                 R`000         R`000            
REVENUE                                          346 013       270 125          
- continued operations                           343 152       266 565          
- discontinued operations                        2 861         3 560            
Cost of sales                                    186 569       150 472          
- continued operations                           185 572       149 299          
- discontinued operations                        997           1 173            
GROSS PROFIT                                     159 444       119 653          
Other operating income                           20 192        7 589            
- continued operations                           20 103        7 589            
- discontinued operations                        89            -                
Gross income                                     179 636       127 242          
Administration, distribution and selling                                        
expenses                                         130 429       108 941          
- continued operations                           127 278       106 427          
- discontinued operations                        3 151         2 514            
PROFIT / (LOSS) FROM OPERATIONS                  49 207        18 301           
Loss on investments (continued operations)       -             36 270           
Finance cost                                     24 781        19 759           
- continued operations                           24 477        19 579           
- discontinued operations                        304           180              
PROFIT / (LOSS) BEFORE TAXATION                  24 426        (37 728)         
Income taxation (expense) / gain                 (11 317)      (1 307)          
- continued operations                           (11 247)      (1 377)          
- discontinued operations                        (70)          70               
PROFIT / (LOSS) AFTER TAXATION                   13 109        (39 035)         
Income from associates                           4 219         50               
Outside shareholders` interest                   (407)         26 751           
NET PROFIT / (LOSS) FOR THE YEAR                 16 921        (12 234)         
TOTAL NET PROFIT / (LOSS) FOR THE YEAR           16 921        (12 234)         
- Continued operations                           18 493        (11 997)         
- Discontinued operations                        (1 572)       (237)            
Weighted average number of shares                88 689        88 689           
Headline earnings per share (cents)              19.07         0.21             
Earnings / (loss) per share (cents)              19.08         (13.79)          
Diluted earnings per share (cents)               18.68         (13.22)          
Reconciliation of basic earnings to headline                                    
earnings                                                                        
Net profit/(loss) for the year                   16 921        (12 234)         
Amortisation of goodwill and dossiers            528           487              
Amortisation and impairment of patents and                                      
trademarks                                       718           -                
Development costs written off                    56            -                
Profit on disposal of property, plant and                                       
equipment                                        (1 562)       -                
Loss on permanent dimunition of investment                                      
property                                         35            -                
Loss on write-off of investments                 109           11 741           
Software development costs written off           113           -                
Start-up costs                                   -             190              
Headline earnings                                16 918        184              
ABRIDGED CASH FLOW STATEMENT FOR THE                                            
YEAR ENDED 31 AUGUST 2002                                                       
                                                       GROUP                    
2002          2001             
                                                 R`000         R`000            
Cash flows from operating activities             32 372        48 819           
- continued operations                           32 462        49 635           
- discontinued operations                        (90)          (816)            
Cash flows from investing activities             (16 055)      4 121            
- continued operations                           (16 262)      4 167            
- discontinued operations                        207           (46)             
Cash flows from financing activities             5 516         (39 325)         
- continued operations                           5 070         (39 920)         
- discontinued operations                        446           595              
Net increase/(decrease) in cash and cash                                        
equivalents                                      21 833        13 615           
Cash and cash equivalents at beginning of year   (6 004)       (19 619)         
Cash and cash equivalents at end of year         15 829        (6 004)          
STATEMENT OF CHANGES IN EQUITY FOR                                              
THE YEAR ENDED 31 AUGUST 2002                                                   
                      Share    Share     Non-      Accumulated Total            
                      Capital  premium   distri-   loss                         
                                         butable                                
reserves                               
                      R`000    R`000     R`000     R`000       R`000            
GROUP                                                                           
Balance at                                                                      
31 August 2000        1 554    126 283   39        (109 874)   18 002           
Fundamental error     -        -         -         (402)       (402)            
Restated balance      1 554    126 283   39        (110 276)   17 600           
Net loss from                                                                   
ordinary activities   -        -         -         (12 234)    (12 234)         
Balance at                                                                      
31 August 2001        1 554    126 283   39        (122 510)   5 366            
Fundamental error     -        -         -         (587)       (587)            
Restated balance      1 554    126 283   39        (123 097)   4 779            
Net profit from                                                                 
ordinary activities   -        -         -         16 921      16 921           
Balance at                                                                      
31 August 2002        1 554    126 283   39        (106 176)   21 700           
OVERVIEW                                                                        
This is the fourth year of Sekunjalo Investments Ltd`s (SIL) listing on the JSE 
Securities Exchange South Africa (JSE). The restructuring                       
plan and growth model, implemented by the Group two years ago, has resulted in a
significant improvement in earnings for the year                                
under review.                                                                   
Group Financial Overview                                                        
The results show a steady but significant improvement in the group`s            
performance:                                                                    
* Headline earnings for the group were R16,918 million (2001: R184 000)         
* Group turnover: R346,013 million (2001: R270,125 million)                     
* Operating profit: R49,207 million (2001: R18,301 million)                     
* Headline Earnings per share of 19.07 cents ( 2001: 0.21 cents)                
* Earnings per share of 19.08 cents (2001: -13,79 cents)                        
REVIEW OF INVESTMENTS                                                           
Sekunjalo Industrial Investments: Premier Fishing SA (Pty) Ltd                  
Premier Fishing is the only large major black controlled and managed fishing    
company in South Africa. Under MD, Mohamed Kajee, the company has restructured, 
resulting in greater operational efficiency and improved earnings.              
The allocation of four-year rights has brought welcome stability to the         
industry. Premier Fishing has been a significant beneficiary, due to its strong 
BEE credentials. The four-year rights allocation, has facilitated further       
capital investment and allowed the company to develop a long-term plan for a    
sustainable approach to fishing resources. The company`s strong presence in     
South and West Coast lobster contributed significantly to export income. The    
depreciation of the Rand for most of the last financial year and premium export 
prices contributed to the strong financial performance.                         
The company has a number of strong brands: South Atlantic Lobster as the export 
brand, Redro and Pecks Anchovette fish spreads and Seagro organic fertiliser.   
Premier Fishing is well positioned to continue with this strong performance due 
to the following:                                                               
* The allocation of four-year rights;                                           
* The global demand for lobster;                                                
* The increased local demand for canned pilchards;                              
* The high global demand for fish meal;                                         
* Growth in the fish spreads and organic fertiliser brands; and                 
* The consolidation of alliances in the industry.                               
Sustainability                                                                  
Premier Fishing shares the commitment of government towards a sustainable       
approach to fishing resources. The stringent manner in which government has     
dealt with companies that illegally exceeded quotas, is positive. Of major      
concern is the poaching of abalone, which has resulted in a significant         
depletion of this resource. The company is committed to developing the abalone  
resource and has invested in an abalone aquaculture farm.                       
Sekunjalo Health Care Ltd (SHC)                                                 
Sekunjalo Health Care, under the leadership of Dr Vincent Msibi, has experienced
challenging times. The health care environment remains a highly competitive one,
due to the dominance of a few major companies. While SHC remains one of the     
largest black health care companies in the country, the reluctance of financial 
institutions to support black health care companies has limited its growth. This
has affected the ability of SHC to compete effectively in the marketplace with  
established health care companies.                                              
Sekpharma (Pty) Ltd                                                             
Sekpharma (Pty) Ltd is the pharmaceutical subsidiary of SHC. Its product range  
includes well-known dermatological brands such as Dermovate and Betnovate,      
asthma medication such as Becotide, Becloforte, Volmax as well as anti-         
microbials such as Fortnum.                                                     
Sekpharma continues to build on its relationship with multinational             
pharmaceutical companies as part of an aggressive expansion strategy aimed at   
gaining significant market share in future. The acquisition of 17 pharmaceutical
dossiers from Glaxo Smith Kline has given the company a solid base from which to
grow its pharmaceutical business.                                               
Promex (Pty) Ltd                                                                
Promex, one of the largest manufacturers of syringes and needles on the African 
continent, remains the dominant supplier to government. Promex is the market    
leader in the manufacture and supply of strongly branded hypodermic syringes,   
needles and related products. It has developed world-class efficiency at its    
plants, that allow it to compete with some of the world`s low-cost producers. Of
concern is the dumping by multinationals of medical consumables on the Southern 
African market, potentially reducing employment and job creation.               
Rapimed (Pty) Ltd                                                               
Rapimed with its branded product, Uricheck, is the market leader in the         
manufacture and distribution of rapid diagnostic products. Products include     
HIV/AIDS rapid diagnostic kits, pregnancy and malaria diagnostic kits. Rapimed  
continues to export to Africa, the Middle East and South America. The           
introduction of ISO 9002 certification will provide the opportunity to export   
into the European market.                                                       
Health System Technologies (Pty) Ltd (HST)                                      
The successful implementation of the health systems information technology      
tender in the Provincial Administration of the Western Cape hospitals of Groote 
Schuur, Tygerberg and Red Cross Childrens Hospital is an example of the success 
of a black company in implementing one of the most sophisticated health         
technology systems worldwide. Through this tender, HST, is able to provide the  
government with health IT systems to better manage hospitals and assist in the  
quality of health care delivery. It is well positioned to obtain further tenders
in the public and private health care sector.                                   
SEKUNJALO INFORMATION TECHNOLOGY                                                
Sekunjalo Enterprise Management Technology (Pty) Ltd (Semtech)                  
Semtech is a niche software product developer, specialising in manufacturing    
workflow and web accounting. The company continues to make progress in          
developing software for the agri-chemical industry and warehouse control        
management industries.                                                          
GROUP PROSPECTS                                                                 
The growth model implemented by SIL will enable it to consolidate and improve   
its performance in the future. The prospects for Premier Fishing as a result of 
the four-year rights allocations and the increased focus on pharmaceuticals by  
Sekunjalo Health Care will position the group to deliver a good performance in  
the year ahead.                                                                 
Sekunjalo and its advisors are engaged in discussions to recover a substantial  
portion of its investment in LeisureNet Ltd.                                    
The audited results have been prepared in accordance with South African         
Statements of Generally Accepted Accounting Practice. Accounting policies       
applied are consistent with those applied in the previous year. These results   
have been audited by the group`s auditors, Fisher Hoffman PKF (Newlands)        
Incorporated, and their unqualified audit opinion is available for inspection at
the company`s registered office.                                                
APPRECIATION                                                                    
The solid performance of the group would not have been possible without Dr      
Wallace Mgoqi, whose wise counsel is sincerely appreciated, as is the vital     
contribution of the directors of SIL and subsidiary companies, the executive    
management team and staff.                                                      
By order of the Board                                                           
Adv WA Mgoqi                                                                    
Chairman                                                                        
Dr MI Surv                                                                     
Chief Executive                                                                 
Cape Town,                                                                      
27 November 2002                                                                
Directors                                                                       
Adv WA Mgoqi (Chairman),                                                        
Dr MI Surv* (Chief Executive Officer),                                         
MY Kajee CA (SA) (Company Secretary),                                           
F Kahn (Financial Director),                                                    
RA Seria,                                                                       
AJ Snyders,                                                                     
KC Patel,                                                                       
Z Kota,                                                                         
D Case                                                                          
*Executive Director                                                             
Registered Address:                                                             
70 Rosmead Avenue,                                                              
Kenilworth, 7708                                                                
Transfer Secretaries:                                                           
Computershare Services Limited                                                  
70 Marshall Street                                                              
Johannesburg, 2001                                                              
Sponsors: Sasfin                                                                
Date: 27/11/2002 12:30:00 PM Produced by the JSE SENS Department                



Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: